TrialPsychopharmacology2016

Clinical safety and hypothalamic-pituitary-adrenal axis effects of the arginine vasopressin type 1B receptor antagonist ABT-436.

David A Katz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.